BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Freynhagen R, Baron R, Kawaguchi Y, Malik RA, Martire DL, Parsons B, Rey RD, Schug SA, Jensen TS, Tölle TR, Ushida T, Whalen E. Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration. Postgrad Med 2021;133:1-9. [PMID: 33423590 DOI: 10.1080/00325481.2020.1857992] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Xu H, Zhang Z, Li Y, Pauer L, Liao S, Zhang F. Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects. J Pain Res 2021;14:537-48. [PMID: 33658841 DOI: 10.2147/JPR.S281483] [Reference Citation Analysis]
2 Hanna R, Bensadoun RJ, Beken SV, Burton P, Carroll J, Benedicenti S. Outpatient Oral Neuropathic Pain Management with Photobiomodulation Therapy: A Prospective Analgesic Pharmacotherapy-Paralleled Feasibility Trial. Antioxidants 2022;11:533. [DOI: 10.3390/antiox11030533] [Reference Citation Analysis]
3 Stanulović V, Hodolic M, Mitsikostas DD, Papadopoulos D. Drug tolerability: How much ambiguity can be tolerated? A systematic review of the assessment of tolerability in clinical studies. Br J Clin Pharmacol 2021. [PMID: 34342031 DOI: 10.1111/bcp.15016] [Reference Citation Analysis]